{
    "url": "https://nationalscreening.blog.gov.uk/2026/01/13/consultation-opens-on-evidence-relating-to-screening-for-copd/",
    "title": "Consultation opens on evidence relating to screening for COPD",
    "authors": [
        "Peggie Huangfu"
    ],
    "categories": [
        "Adult screening"
    ],
    "pub_date": "2026-01-13T08:54:23+00:00",
    "content": [
        {
            "text": "The UK National Screening Committee (UK NSC) has opened a consultation on evidence relating to\u00a0screening for Chronic Obstructive Pulmonary Disease (COPD) in\u00a0the\u00a0general adult population.\u202f\u00a0"
        },
        {
            "text": "COPD\u00a0is one of the health conditions the committee reviews regularly for evidence relating to\u00a0population\u00a0screening.\u00a0"
        },
        {
            "text": "Evidence maps\u202fare typically the first step in the UK NSC\u202fprocess of reviewing evidence. We are asking individuals and organisations to provide feedback on the findings and conclusions of a 2025 evidence map on screening for\u00a0COPD in adults.\u00a0"
        },
        {
            "text": "The evidence map was commissioned to review literature on the topic published since our last evidence review in 2018.\u202f\u202f\u00a0"
        },
        {
            "text": "The\u00a02025 evidence map\u202fconcludes that the volume and type of new evidence related to screening for\u00a0COPD in adults is currently insufficient to justify more in-depth work at this time. It recommends\u00a0that screening for COPD should be re-considered in 3 years\u2019 time.\u00a0"
        },
        {
            "heading": 2,
            "text": "How to respond"
        },
        {
            "heading": 2,
            "text": "About COPD"
        },
        {
            "text": "COPD is a group of progressive lung conditions characterised by the inflammation and irreversible damage to pulmonary air passages that gradually reduces airflow into the lungs.\u00a0The main symptoms\u00a0of COPD\u00a0include\u00a0increasing breathlessness when active and persistent coughs with\u00a0phlegm. However, airflow obstruction without symptoms is also common in COPD. "
        },
        {
            "text": "If left untreated, these lung conditions will progressively impair quality of life, resulting in long-term disabilities and increased mortality. Smoking tobacco has been shown to be the main cause of COPD and\u00a0is responsible for\u00a080% to 90% of cases. Epidemiological studies have found that 15% to 50% of all smokers will develop COPD.\u00a0"
        },
        {
            "heading": 2,
            "text": "The 2025 evidence map"
        },
        {
            "text": "The 2025 evidence map\u00a0identifies\u00a0some new\u00a0evidence\u00a0published since the 2018\u00a0review, including evidence on:"
        },
        {
            "heading": 2,
            "text": "Keep up to date"
        },
        {
            "text": "The UK NSC blog provides up to date news from the UK NSC. You can\u202fregister to receive updates\u202fdirect to your inbox, so there is no need to keep checking for new articles. If you have any questions about this blog article, or about the work of the UK NSC, please email\u202fuknsc@dhsc.gov.uk.\u202f"
        }
    ]
}